Treatment With Unlabeled mAb BR96 After Radioimmunotherapy With177Lu-Dota-Br96 in a Syngeneic Rat Colon Carcinoma Model

Cancer Biotherapy and Radiopharmaceuticals - United States
doi 10.1089/cbr.2011.1132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Role of CD8-positive Cells in Radioimmunotherapy Utilizing 177Lu-mAbs in an Immunocompetent Rat Colon Carcinoma Model

EJNMMI Research
Nuclear MedicineRadiologyImaging
2015English

Spillage of Bacterial Products During Colon Surgery Increases the Risk of Liver Metastases Development in a Rat Colon Carcinoma Model.

OncoImmunology
OncologyAllergyImmunology
2018English

Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2016English

A Rat Model of Syngeneic Bone Marrow Transplantation During Breast Cancer Therapy

Bone Marrow Transplantation
TransplantationHematology
2003English

Gene Expression in the Hippocampus in a Rat Model of Premenstrual Dysphoric Disorder After Treatment With Baixiangdan Capsules

Frontiers in Psychology
Psychology
2018English

Radioimmunotherapy in the Treatment of Malignancies

Siberian Journal of Oncology
Cancer ResearchOncology
2016English

The Treatment of Metastatic Prostate Carcinoma With BNCT in the ITU TRIGA MARKII Reactor on Rat Model

Medical Science and Discovery
2016English

Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma

English

A Colon-Specific Prodrug of Metoclopramide Ameliorates Colitis in an Experimental Rat Model

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy